Lung cancer: future prospects.
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005260:Female; D005544:Forecasting; D006801:Humans; D053685:Laser Therapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery; D008297:Male; D008403:Mass Screening; D012306:Risk; D012907:Smoking; D014916:Whole-Body Irradiation
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D003520:Cyclophosphamide